Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Inflammatory Bowel Disease
09. January 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2820
Articles 1 - 20 / 56385
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.
Inflamm Bowel Dis
Turner D, Lomax KG, Veereman G, Griffiths AM, Kierku, Kang B, Berezny K, Padgett L, Mao G, Zitser Y, Strauss RS, Verhoeven J, Adedokun OJ, Hyams JS.
PMID: 41503939 [PubMed - as supplied by publisher]
Short- and Long-Term Outcomes of Endoscopic Resection for Serrated Lesions in Patients With Ulcerative Colitis: AÂ Retrospective Exploratory Study.
Dig Endosc
Nishio M, Hirasawa K, Kunisaki R, Nozaki K, Morohashi K, Kanemura T, Atsusaka R, Azuma D, Sawada A, Kobayashi R, Sato C, Ogashiwa T, Kimura H, Chiba S, Maeda S.
PMID: 41503722 [PubMed - indexed for MEDLINE]
Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations.
AJR Am J Roentgenol
Dillman JR, Rieder F, Baker ME, Fletcher JG, Bruining DH, Kugathasan S, Denson LA.
PMID: 41499701 [PubMed - as supplied by publisher]
A Multimodal Feature Fusion Model for Predicting Secondary Loss of Response After Infliximab Treatment in Crohn's Disease Patients: A Multicenter Study.
Dig Endosc
Rong C, Liu Y, Hu J, Cheng T, Tai Z, Li S, Shen Y, Zhang B, Gao Y, Zheng X, Liu K, Sun M, Wu X.
PMID: 41499486 [PubMed - indexed for MEDLINE]
Managing Acute Severe Ulcerative Colitis in 2025 and Beyond.
Curr Gastroenterol Rep
Goyal MK, Hassan SA, Berinstein JA.
PMID: 41499005 [PubMed - indexed for MEDLINE]
Non-Responders to Biologic Disease Modifying Antirheumatic Treatment for Inflammatory Bowel Diseases.
Mediators Inflamm
Gadzhanova S, Roughead E.
PMID: 41498032 [PubMed - indexed for MEDLINE]
CV-SCAN (Crystal Violet Staining for Colitis-Associated Neoplasia): A Novel Endoscopic Staining Method to Detect Paneth Cell Metaplasia and Ulcerative Colitis (UC)-Associated Neoplasia in UC.
Dig Endosc
Tomioka A, Chiya N, Kurihara C, Okada Y, Narimatsu K, Higashiyama M, Komoto S, Hokari R.
PMID: 41496657 [PubMed - indexed for MEDLINE]
Gastrointestinal resection is associated with urolithiasis severity among inflammatory bowel disease patients.
Can J Urol
Durbhakula V, Savin Z, Savin-Shalom E, Gold SL, Gupta K, Frangopoulos E, Gallante B, Atallah WM, Gupta M.
PMID: 41496544 [PubMed - indexed for MEDLINE]
Causal effects of inflammatory bowel disease on brain structure: A Mendelian randomization study.
Medicine (Baltimore)
He Y, He J, Chen C.
PMID: 41496026 [PubMed - indexed for MEDLINE]
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives.
Mol Biomed
Yang X, Guo H, Zou M.
PMID: 41495287 [PubMed - indexed for MEDLINE]
Advances and prospects of microenvironment-targeted nanotherapeutics for ulcerative colitis: evolving paradigms in the precision gut microenvironment.
Int J Pharm
Lu H, Zhang W, Wu Z, Peng Y, Liu F, Gao S, Deng L.
PMID: 41494608 [PubMed - as supplied by publisher]
Correlating Quality of Life with Point-of-Care Intestinal Ultrasound in Inflammatory Bowel Disease (CUALITY Study).
Acta Gastroenterol Belg
Parra Izquierdo V, Ernest Suarez K, Argollo M, Frías-Ordoñez J, Orduz G, Puentes Manosalva F, Vargas M, Cubillos S, Eggermont E, Verstockt B.
PMID: 41493319 [PubMed - indexed for MEDLINE]
Decoding ulcerative colitis pathogenesis through transcriptomics: from dysregulated gene networks to targeted intervention strategies.
J Transl Autoimmun
Zhu X, Yang Y, Zhu Y.
PMID: 41492412 [PubMed]
Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial.
BMJ Open
Zhou Y, Liu H, Qian X, Zhang X, Xu F.
PMID: 41490862 [PubMed - indexed for MEDLINE]
Association of Mycobacterium Avium paratuberculosis with Crohn's Disease: A large multicentre study from TB endemic region.
Clin Infect Dis
Vuyyuru SK, Singh U, Das P, Basant S, Singh V, Sinha SK, Sharma K, Ramakrishnan BS, Kannan P, Pokharna R, Malhotra B, Bhatia S, Dhali GK, Sarkar R, Sharma C, Dattagupta S, Singh M, Kochhar R, Vishnubhatla S, Ahuja V.
PMID: 41488976 [PubMed - as supplied by publisher]
Efficacy and Safety of Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Gastroenterology Res
Brennan G, Meine GC, Delgado LM, Santo P.
PMID: 41488821 [PubMed]
MicroRNAs as multifaceted regulators and therapeutic targets in ulcerative colitis.
Front Immunol
Wang X, Jiang N, Yin W, Cui X.
PMID: 41488657 [PubMed - indexed for MEDLINE]
The role of Akkermansia muciniphila in the regulation of inflammatory bowel disease: intestinal immunity and metabolism.
Front Immunol
Xu W, Li A, Jing H, Zhang X, Dong X, Song Z, Wu N, Zheng S.
PMID: 41488633 [PubMed - indexed for MEDLINE]
Modular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier.
Front Immunol
Yin L, Sun CY, Chen GL, Xiang Z, Hu BQ, Zhou F, Wang Q.
PMID: 41488628 [PubMed - indexed for MEDLINE]
Genetically Validated Immune Susceptibility Markers for Crohn's Disease: A Multi-Omics Mendelian Randomization Analysis.
JGH Open
Li Z.
PMID: 41487707 [PubMed]
Articles 1 - 20 / 56385
Page 1 of 2820
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy